OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $157,000 | -65.2% | 91,250 | -57.3% | 0.00% | -60.0% |
| Q3 2015 | $451,000 | -19.2% | 213,700 | +89.6% | 0.01% | 0.0% |
| Q2 2015 | $558,000 | -88.8% | 112,700 | -82.3% | 0.01% | -90.0% |
| Q1 2015 | $4,989,000 | +95.5% | 637,176 | +51.3% | 0.05% | +194.1% |
| Q4 2014 | $2,552,000 | +9.4% | 421,103 | -23.1% | 0.02% | +41.7% |
| Q3 2014 | $2,333,000 | +69.7% | 547,716 | +146.2% | 0.01% | +71.4% |
| Q2 2014 | $1,375,000 | -20.0% | 222,500 | -15.9% | 0.01% | -22.2% |
| Q1 2014 | $1,718,000 | +381.2% | 264,457 | +316.0% | 0.01% | +350.0% |
| Q4 2013 | $357,000 | +207.8% | 63,568 | +236.1% | 0.00% | +100.0% |
| Q3 2013 | $116,000 | – | 18,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |